Phase II, 2nd Line Melanoma - RAND Monotherapy
Clinical trial NCT00612664 · COMPLETED
Trial details
- NCT number
- NCT00612664
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-10-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.